Ovulation tracking app Premom is adding four new membership tiers to its offering. The membership is designed to help women better understand and optimize their menstrual cycles to increase the likelihood of conception. Premom memberships include free at-home fertility testing kits, advanced AI ovulation predictions with patented image and interpretation technology to quantify a woman’s hormone tests, and customized, quality care and…
Oova has announced the official launch of Oova Kit, its at-home urine test that measures two key fertility hormones with the same accuracy as a blood test. Combined with an app, Oova tracks, predicts, and confirms ovulation, allowing women to fully understand their fertility. The U.S.-based femtech company was founded in 2017 by Amy Divaraniya and has received $1.5M in seed funding…
Reuters has reported that Iran, an Islamic country that restricts contact between unrelated men and women, has launched Hamdam (Companian), a state-approved dating app to promote marriages to combat a drop in fertility rates. The app was developed by a state-affiliated Islamic cultural body, matches and advises singles looking for a marriage partner. Officials have expressed concern that Iran’s population could be…
Inito, a new home fertility test, announced its launch to the U.S. market. The Inito device, paired with a smartphone app, measures the actual hormone values for estrogen, luteinizing hormone and progesterone, and gives users data to guide decisions through the conception process. In addition to the U.S. launch, Inito is also launching a new ‘Hormone Charts’ feature in the app allowing…
INVO Bioscience, a medical device company focused on commercializing the world’s only in vivo Culture System (IVC), INVOcell, an effective and affordable treatment for patients diagnosed with infertility, today announced the appointment of Barbara Levy, M.D., FACOG, FACS as the Company’s Senior VP, Global Clinical Integration. Dr. Levy recently serving as Vice President, Health Policy at the American College of Obstetricians and Gynecologists…
TMRW Life Sciences, the life sciences technology firm providing the world’s first automated platform for tracking, monitoring, and storage of frozen eggs and embryos used in in vitro fertilization (IVF), announced the completion of a $105M Series C equity and debt financing today. The equity round was led by Transformation Capital and includes participation from GV (formerly Google Ventures), Casdin Capital, Peter Thiel, Anne and Susan…
Eggschain, a healthcare technology company that combines genetics and blockchain to track genetic material, today announced its pioneering, patented solution for tracking and tracing the storage and transfer of blood, genome, tissues, organs, DNA, RNA, sperm, eggs, embryos, and other biospecimens. This new supply chain solution aims to provide a universal tracing and tracking platform to deliver peace of mind for people and families…
Kindbody today announced that Gwyneth Paltrow, Gabrielle Union, Hannah Bronfman, Yael Cohen, Sophia Amoruso, Amy Griffin, and other mission-driven celebrities have contributed to the company’s $62 million Series C fundraise announced two weeks ago. The strategic investments from celebrity health advocates and champions of equality will be used to accelerate the company’s already rapid growth and further its mission of increasing access to fertility and family-building services worldwide. “I am honored…
